| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2021 | ORGANOS, INC. | 130 STANLEY HALL | BERKELEY | CA | 94720-0001 | ALAMEDA | USA | R44HL152905 | Combined Computational and Cardiac Microphysiological System Approach for Drug-Induced Proarrhythmia Screening | 000 | 2 | NIH | 10/11/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $351,332 ) |
| | 2023 | 2023 | ORGANOS, INC. | 130 STANLEY HALL MC 3220 | BERKELEY | CA | 94720-0001 | ALAMEDA | USA | R44TR004250 | High-throughput Human Micro-Heart Muscle for Drug Discovery | 000 | 2 | NIH | 5/5/2023 | $351,332 |
|
| Issue Date FY: 2022 ( Subtotal = $622,880 ) |
| | 2022 | 2022 | ORGANOS, INC. | 130 STANLEY HALL MC 3220 | BERKELEY | CA | 94720-0001 | ALAMEDA | USA | R44TR004250 | High-throughput Human Micro-Heart Muscle for Drug Discovery | 000 | 1 | NIH | 8/11/2022 | $622,880 |
|
| Issue Date FY: 2021 ( Subtotal = $537,114 ) |
| | 2021 | 2021 | ORGANOS, INC. | 130 STANLEY HALL MC 3220 | BERKELEY | CA | 94720-0001 | ALAMEDA | USA | R44HL152905 | Combined Computational and Cardiac Microphysiological System Approach for Drug-Induced Proarrhythmia Screening | 001 | 2 | NIH | 8/12/2021 | $537,114 |
| | 2021 | 2020 | ORGANOS, INC. | 3841 CAMPOLINDO DR | MORAGA | CA | 94556-1546 | CONTRA COSTA | USA | R44HL152905 | Combined Computational and Cardiac Microphysiological System Approach for Drug-Induced Proarrhythmia Screening | 000 | 1 | NIH | 1/5/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $925,511 ) |
| | 2020 | 2020 | ORGANOS, INC. | 3841 CAMPOLINDO DR | MORAGA | CA | 94556-1546 | CONTRA COSTA | USA | R44HL152905 | Combined Computational and Cardiac Microphysiological System Approach for Drug-Induced Proarrhythmia Screening | 000 | 1 | NIH | 9/23/2020 | $925,511 |
|
|
